Skip to main content
SpringerLink
Log in

Anaesthetics/antibacterials/immune globulin

Acquired haemophilia (first reports) in an elderly patient, treated with rituximab: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Kesler A, Axt R, Schmucker R, Gartner W.First report of elimination of acquired factor-V-inhibitor using Rituximab in Guillain-Barre-Syndrome: A case report. Hamostaseologie 31: A70 abstr. P11-11, No. 1, Feb 2011. Available from: URL: www.haemostaseologie-online.com - Germany

Download references

Additional information

COMMENT

Editorial Comment: A search of AdisBase, Medline, Embase and the WHO ADR database did not reveal any previous case reports of acquired haemophilia associated with immune globulin, meropenem or voriconazole.

Key words

therapeutic use; Rituximab; adverse reactions; Elderly; drug-induced; Haemophilia; Voriconazole; Anaesthetics; Meropenem; Immune-globulin; treatment

An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage; First published case repo

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anaesthetics/antibacterials/immune globulin. React. Wkly. 1426, 9 (2012). https://doi.org/10.2165/00128415-201214260-00029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00029

Keywords

Search

Navigation